Prognostic Value of Systemic Immune Inflammation Index in Malignant Ischemic Stroke: A Study on Patient Selection and Timing of Surgical Decompression
Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2023, Vol 1, Issue 4
Abstract
Background: Ischemic stroke is a substantial health concern with long-term neurological consequences and economic implications. Inflammation worsens secondary brain injury, prompting the search for prognostic biomarkers. The optimal approach for treating malignant ischemic stroke, patient selection, and intervention timing remain intricate due to patient diversity. Methods: We investigate the systemic immune inflammation index (SII) predictive value for surgical decompression timing and patient selection in malignant ischemic stroke. We include patients who underwent surgical decompression for ischemic stroke-induced malignant brain edema in the past five years. Retrospective data were collected, including demographics, history, laboratory results, imaging, and surgical details. SII was calculated using platelet, neutrophil, and lymphocyte counts. Descriptive statistics and multivariate regression models were used. Results: In this study involving 80 patients, we evaluated the impact of decompressive craniectomy on ischemic stroke outcomes. Patients were divided into the Decompression Group (n=39) and Non-Decompression Group (n=41). Gender distribution, hypertension, diabetes mellitus, atrial fibrillation, and hemorrhage occurrence showed no significant differences between the groups. However, the Decompression Group had higher NIHSS scores at presentation (18.1±4.6 vs. 14.8±4.7, P=0.02) and discharge (17±5 vs. 11.2±4, P=0.001). SII at presentation and control were significantly higher in the Decompression Group (P=0.04 and P=0.05, respectively). Hospitalization duration on the 10th day was longer in the Decompression Group (39.5±28.8 vs. 11.8±5.6, P=0.001). Conclusions: Our study examines SII's potential as a prognostic marker for surgical decompression timing and patient selection in malignant ischemic stroke. Despite limitations, we highlight the complex relationship between systemic inflammation, stroke severity, and post-surgical outcomes. Further research with larger cohorts must validate SII's utility and refine its application in ischemic stroke management. Continued investigation is crucial to establish SII's role as a predictive tool in guiding clinical decisions.
Authors and Affiliations
Tolga Gediz, Elif Gencer
Keywords
Related Articles
- EP ID EP733908
- DOI https://doi.org/10.5281/zenodo.10019794
- Views 45
- Downloads 1
Comparison of Peritoneal Catheter Insertion Techniques: A Single-Center Experience Comparing Percutaneous and Laparoscopic Approaches
Background: There is still no consensus on the best approach for the insertion of the peritoneal dialysis catheter. We aimed to compare the results of the percutaneous Sildenger and laparoscopic surgical peritoneal dialy...
The Impact of Sodium-Glucose Co-Transporter-2 Inhibitors on Weight Loss in Obesity
Obesity is a chronic medical condition characterized by excessive body fat accumulation, posing health risks. Obesity is influenced by genetic, environmental, behavioral, and socioeconomic factors, emphasizing its comple...
The Assessment of Stroke Patients Using the Functional Independence Measurement Scale
Background: The objectives of this study are; evaluating hemiplegic patients using the "Functional Independence Measurement Scale (FIM)", assessing the long-term daily life activities of patients receiving and not receiv...
Diabetes Mellitus is Frequent, But Retinopathy is Rare in Acromegaly: A Cross-sectional Study
Background: The roles of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) in diabetic retinopathy (DR) are well recognized, but the prevalence and pathogenesis of retinopathy in acromegaly are not fully under...
A Rare Case of Multiple and Ectopic Parathyroid Adenoma
This is a letter to the editors. An abstract is not available